Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial. - Hao, Yun; Xie, Fei; Zhou, Yongjie; Li, Chuan; Zhang, Xiaoyun; Shen, Junyi; Yao, Minghong; Sun, Xin; Zhou, Jin; Wen, Tianfu; Peng, Wei (Trials, 2024)